Cliniko vs CorpAxe: Revenue, Funding & Team Size Compared
Cliniko generates $1.5M in revenue; CorpAxe generates $1.6M. CorpAxe and Cliniko are close to the same size by revenue. The table below compares Cliniko and CorpAxe on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $1.5M | $1.6M |
| Valuation | Not disclosed | $16M |
| Team size | 14 | 35 |
| Founded | 2010 | 2014 |
| HQ | Melbourne, Australia | New York, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Cliniko at a glance
Cliniko generates $1.5M in revenue with 14 employees, headquartered in Melbourne, Australia.
- Revenue
- $1.5M
- Team size
- 14
- Founded
- 2010
Cliniko is practice management software that makes running your allied health clinic quicker and easier, freeing up your time to focus on treating your patients. You’ll find secure, cloud-based features that’ll help you to manage your…
CorpAxe at a glance
CorpAxe generates $1.6M in revenue with 35 employees, headquartered in New York, United States.
- Revenue
- $1.6M
- Valuation
- $16M
- Team size
- 35
- Founded
- 2014
Provider of a corporate access events aggregator, resource management, broker vote and budgeting platform intended to simplify corporate access and research management. The company's platform permits for price discovery, accuracy of…
Other Cliniko alternatives
Cliniko competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Cliniko vs CorpAxe: frequently asked questions
Is Cliniko or CorpAxe bigger?
CorpAxe is the bigger company by revenue, at $1.6M against $1.5M for Cliniko.
How much revenue does Cliniko make?
Cliniko generates $1.5M in annual revenue with a team of 14.
How much revenue does CorpAxe make?
CorpAxe generates $1.6M in annual revenue with a team of 35.